EVENTS · ABT
PEERS
EARNINGS
Abbott Laboratories is a global healthcare company developing, manufacturing, and marketing products that support diagnosis, treatment, nutrition, and disease management. Its business is organized across Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The pharmaceutical portfolio includes branded generic medicines used across therapeutic areas, while diagnostic offerings cover laboratory, molecular, point-of-care, and rapid testing systems. Abbott’s nutrition business serves infants, children, and adults through specialized formulas, supplements, and wellness products. Its medical-device portfolio includes technologies for cardiovascular care, diabetes management, and neuromodulation, including continuous glucose monitoring systems and minimally invasive cardiac devices. Abbott Laboratories serves hospitals, laboratories, physicians, pharmacies, retailers, and consumers across international healthcare markets. Through its combination of essential medicines, diagnostic infrastructure, nutritional support, and medical technologies, the company occupies a broad role within the healthcare sector, connecting clinical decision-making with long-term disease management and everyday health needs.
| Series | 1W | 1M |
|---|---|---|
| ABT | +12.5% | +17.7% |
| Peers | +5.9% | +12.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 91 | 84 |
No company news, with medical device makers broadly higher as a group that day
| Series | 1W | 1M |
|---|---|---|
| ABT | +12.5% | +17.7% |
| Peers | +5.9% | +12.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 91 | 84 |
